Fulgent Genetics, Inc. (FLGT): Price and Financial Metrics

Fulgent Genetics, Inc. (FLGT): $62.64

2.14 (+3.54%)

POWR Rating

Component Grades














  • FLGT scores best on the Quality dimension, with a Quality rank ahead of 87.9% of US stocks.
  • FLGT's strongest trending metric is Momentum; it's been moving down over the last 170 days.
  • FLGT ranks lowest in Stability; there it ranks in the 2nd percentile.

FLGT Stock Summary

  • FLGT's one year PEG ratio, measuring expected growth in earnings next year relative to current common stock price is 0.29 -- higher than merely 1.53% of US-listed equities with positive expected earnings growth.
  • With a year-over-year growth in debt of 667.55%, Fulgent Genetics Inc's debt growth rate surpasses 98% of about US stocks.
  • Revenue growth over the past 12 months for Fulgent Genetics Inc comes in at 666.64%, a number that bests 98.74% of the US stocks we're tracking.
  • Stocks with similar financial metrics, market capitalization, and price volatility to Fulgent Genetics Inc are UAVS, EOSE, MYOV, OCX, and URGN.
  • Visit FLGT's SEC page to see the company's official filings. To visit the company's web site, go to www.fulgentgenetics.com.

FLGT Valuation Summary

  • FLGT's price/sales ratio is 3; this is 21.05% lower than that of the median Healthcare stock.
  • Over the past 60 months, FLGT's price/sales ratio has gone down 13.3.
  • Over the past 60 months, FLGT's EV/EBIT ratio has gone up 22.7.

Below are key valuation metrics over time for FLGT.

Stock Date P/S P/B P/E EV/EBIT
FLGT 2021-08-31 3.0 3.0 5.5 4.0
FLGT 2021-08-30 3.0 3.0 5.5 4.0
FLGT 2021-08-27 3.0 3.0 5.6 4.1
FLGT 2021-08-26 3.1 3.1 5.7 4.2
FLGT 2021-08-25 3.1 3.1 5.7 4.2
FLGT 2021-08-24 3.0 3.0 5.6 4.1

FLGT's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • FLGT has a Quality Grade of C, ranking ahead of 74.39% of graded US stocks.
  • FLGT's asset turnover comes in at 1.214 -- ranking 12th of 81 Healthcare stocks.
  • MGLN, UHS, and ADUS are the stocks whose asset turnover ratios are most correlated with FLGT.

The table below shows FLGT's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 1.214 0.793 1.237
2021-03-31 1.514 0.793 1.595
2020-12-31 1.489 0.787 1.426
2020-09-30 1.037 0.692 0.646
2020-06-30 0.522 0.559 0.028
2020-03-31 0.472 0.565 -0.007

FLGT Price Target

For more insight on analysts targets of FLGT, see our FLGT price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $103.00 Average Broker Recommendation 1.5 (Moderate Buy)

FLGT Stock Price Chart Interactive Chart >

Price chart for FLGT

FLGT Price/Volume Stats

Current price $62.64 52-week high $189.89
Prev. close $60.50 52-week low $53.97
Day low $59.12 Volume 330,000
Day high $62.83 Avg. volume 608,721
50-day MA $85.85 Dividend yield N/A
200-day MA $84.96 Market Cap 1.87B

Fulgent Genetics, Inc. (FLGT) Company Bio

Fulgent Genetics, Inc., a technology company, focuses on providing genetic testing services to physicians with clinically actionable diagnostic information. It intends to provide tests to hospitals and medical institutions. The company was formerly known as Fulgent Diagnostics, Inc. and changed its name to Fulgent Genetics, Inc. in August 2016. The company was founded in 2011 and is based in Temple City, California.

FLGT Latest News Stream

Event/Time News Detail
Loading, please wait...

FLGT Latest Social Stream

Loading social stream, please wait...

View Full FLGT Social Stream

Latest FLGT News From Around the Web

Below are the latest news stories about Fulgent Genetics Inc that investors may wish to consider to help them evaluate FLGT as an investment opportunity.

ARGI Investment Services, LLC Buys BTC iShares MSCI Emerging Markets Multifactor ETF, Hartford ...

Louisville, KY, based Investment company ARGI Investment Services, LLC (Current Portfolio) buys BTC iShares MSCI Emerging Markets Multifactor ETF, Hartford Multifactor Developed Markets (ex-US) ETF, SPDR Semiconductors ETF, iShares PHLX SOX Semiconductor Sector Index Fund, First Trust NASDAQ Clean Edge Green Energy Idx Fd, sells BTC iShares MSCI Emerging Markets Min Vol Factor E, Invesco Solar ETF, ARK Next Generation Internet ETF, Invesco WilderHill Clean Energy ETF, Comerica Inc during the 3-m

Yahoo | January 28, 2022

Fulgent Genetics: Sell Volatility

No summary available.

Seeking Alpha | January 26, 2022

New Strong Buy Stocks for January 26th

FLGT, LPX, STC, GFED, and FBNC have been added to the Zacks Rank #1 (Strong Buy) List on January 26th.

Yahoo | January 26, 2022

This Breakout Healthcare Growth Stock Is Too Cheap to Miss

Before the pandemic, Fulgent Genetics (NASDAQ: FLGT) was a little-known genetic testing business with grand ambitions but limited means. Let's take a brief walk through Fulgent Genetics' business and the inexpensive valuation of its shares to see if it might be a good fit for your portfolio in 2022. The bottom line with Fulgent Genetics is that the company's early pandemic pivot into providing coronavirus testing has built strong financial and logistical foundations that it can now use to grow with abandon.

Yahoo | January 26, 2022

Cordasco Financial Network Buys Exponent Inc, Bank of America Corp, L3Harris Technologies Inc, ...

Philadelphia, PA, based Investment company Cordasco Financial Network (Current Portfolio) buys Exponent Inc, Bank of America Corp, L3Harris Technologies Inc, iShares MSCI Emerging Markets ETF, Wells Fargo, sells Danimer Scientific Inc, Deere, Vanguard Growth ETF, Ameriprise Financial Inc, Eli Lilly and Co during the 3-months ended 2021Q4, according to the most recent filings of the investment company, Cordasco Financial Network.

Yahoo | January 25, 2022

Read More 'FLGT' Stories Here

FLGT Price Returns

1-mo -38.37%
3-mo -24.46%
6-mo -32.47%
1-year -43.31%
3-year 1,527.01%
5-year 392.84%
YTD -37.73%
2021 93.07%
2020 303.88%
2019 306.94%
2018 -27.63%
2017 -62.14%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!

Page generated in 0.7635 seconds.